Celltrion’s flagship autoimmune disease treatment Remsima (Celltrion) Celltrion is reporting continued growth in prescription rates across Asian...
Celltrion
Injection clinical trial filing in H1 2026; oral drug to follow in H2 2028 A Celltrion sculpture...
R&D-rooted CEO maps out 40 biosimilars, 16 new drug filings by 2038 Celltrion CEO Seo Jin-seok (Park...